Decreased Sclerostin Secretion in Humans and Mice With Nonalcoholic Fatty Liver Disease

Decreased Sclerostin Secretion in Humans and Mice With Nonalcoholic Fatty Liver Disease

ObjectivesGrowing evidence argues for a relationship between liver and bone metabolisms. Sclerostin is a secreted glycoprotein and could antagonize osteoblast-mediated bone formation. Previous studies indicated that circulating sclerostin levels may be associated with metabolic parameters with incon...

Full description

Bibliographic Details
Main Authors: Fangli Zhou, Yan Wang, Yujue Li, Mengjia Tang, Shan Wan, Haoming Tian, Xiang Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Endocrinology
Subjects:
sclerostin
NAFLD
fatty liver index
bone metabolism
triglyceride
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.707505/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.707505/full

Similar Items